Literature DB >> 12196367

Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet.

P M Ellis1, P N Butow, M H N Tattersall.   

Abstract

BACKGROUND: To evaluate the impact of an educational booklet on women's knowledge of and willingness to participate in a randomized clinical trial of treatment for breast cancer.
MATERIALS AND METHODS: Women undergoing surgery for newly diagnosed early stage breast cancer were randomized to receive, or not, an information booklet explaining the need for and manner in which randomized trials are conducted.
RESULTS: Eighty-three women with newly diagnosed early stage breast cancer completed a questionnaire assessing attitudes to random clinical trials (RCTs) and were randomized to receive usual information treatment options provided from their oncologist, or the educational booklet in addition to usual information from their oncologist (42 usual information, 41 booklet). Fewer women who received the clinical trials booklet (40% versus 47%) would consider participating in the hypothetical clinical trial (P = 0.6). Mean knowledge scores increased for both groups; moreover, women who did not receive the booklet showed similar improvements to women who received the booklet [mean difference 0.09, 95% confidence interval (CI) -0.66 to 0.83]. In a multivariate analysis women who would consider participating in the clinical trial were more anxious [odds ratio (OR) 5.9, P = 0.02] had involved lymph nodes (OR 5.8, P = 0.02) and were less influenced by negative aspects of clinical trials (OR 7.7, P = 0.0001). After adjustment for these variables women who received the educational booklet were significantly less likely to consider trial participation (OR 0.22, P = 0.05).
CONCLUSIONS: Educating women about clinical trials in this manner appears ineffective in improving recruitment to RCTs. Women appear to be more influenced by their perception of risk than understanding. This finding has ethical implications for communication of information about RCTs.

Entities:  

Mesh:

Year:  2002        PMID: 12196367     DOI: 10.1093/annonc/mdf255

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  22 in total

Review 1.  Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate.

Authors:  Gero Luschin; Marion Habersack; Irmina-Anna Gerlich
Journal:  BMC Med Res Methodol       Date:  2012-03-11       Impact factor: 4.615

2.  Training community health workers about cancer clinical trials.

Authors:  Lidia Schapira; Russell Schutt
Journal:  J Immigr Minor Health       Date:  2011-10

3.  Patient knowledge and information-seeking about personalized cancer therapy.

Authors:  Deevakar Rogith; Rafeek A Yusuf; Shelley R Hovick; Bryan M Fellman; Susan K Peterson; Allison M Burton-Chase; Yisheng Li; Elmer V Bernstam; Funda Meric-Bernstam
Journal:  Int J Med Inform       Date:  2016-01-18       Impact factor: 4.046

Review 4.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

5.  Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.

Authors:  Linda Fleisher; Dominique G Ruggieri; Suzanne M Miller; Sharon Manne; Terrance Albrecht; Joanne Buzaglo; Michael A Collins; Michael Katz; Tyler G Kinzy; Tasnuva Liu; Cheri Manning; Ellen Specker Charap; Jennifer Millard; Dawn M Miller; David Poole; Stephanie Raivitch; Nancy Roach; Eric A Ross; Neal J Meropol
Journal:  Patient Educ Couns       Date:  2014-04-21

Review 6.  Strategies for increasing recruitment to randomised controlled trials: systematic review.

Authors:  Patrina H Y Caldwell; Sana Hamilton; Alvin Tan; Jonathan C Craig
Journal:  PLoS Med       Date:  2010-11-09       Impact factor: 11.069

7.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14

8.  The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.

Authors:  S M Miller; S V Hudson; B L Egleston; S Manne; J S Buzaglo; K Devarajan; L Fleisher; J Millard; N Solarino; J Trinastic; N J Meropol
Journal:  Psychooncology       Date:  2012-02-14       Impact factor: 3.894

9.  A comparison of patient knowledge of clinical trials and trialist priorities.

Authors:  P Cameron; G R Pond; R Y Xu; P M Ellis; J R Goffin
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

10.  Improving awareness of cancer clinical trials among Hispanic patients and families: audience segmentation decisions for a media intervention.

Authors:  Gwendolyn P Quinn; Jessica McIntyre; Luis E Gonzalez; Teresita Muñoz Antonia; Prado Antolino; Kristen J Wells
Journal:  J Health Commun       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.